Latest filing published 19 May 2025 for REPLIGEN CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Konstantin Konstantinov span 2 companies, the busiest being Codiak BioSciences, Inc. and Repligen Corp. The record holds 15 filings, for trades running from 8 June 2021 to 15 May 2025.
The open-market record consists of 7 sales worth €159k, with no purchase. The rest of the record consists of 4 share grants and 4 option exercises.
On 19 May 2025 came the latest disclosure, a share grant in Repligen Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations